Lipolysis of the semi-solid self-emulsifying excipient Gelucire® 44/14 by digestive lipases

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1781, Issue 8, 2008, Pages 367-375

  Fernandez, Sylvie ^a,b   Rodier, Jean David ^b   Ritter, Nicolas ^b   Mahler, Bruno ^b   Demarne, Frédéric ^b   Carrière, Frédéric ^a   Jannin, Vincent ^b  

^a Centre National de la Recherche Scientifique   (France)

^b GATTEFOSSÉ SAS   (France)

Author keywords

Lipase; Lipolysis; Macrogolglycerides; Oral drug delivery; Semi solid excipient, PEG esters

Indexed keywords

ACYLGLYCEROL; CARBOXYLESTERASE; GELUCIRE; HUMAN PANCREATIC LIPASE RELATED PROTEIN 2; LABRASOL; MACROGOL; MACROGOL STEARATE; PANCREAS EXTRACT; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE;

ARTICLE; DIGESTION; ENZYME ACTIVITY; LIPOLYSIS; PANCREAS JUICE; PRIORITY JOURNAL; ROOM TEMPERATURE;

ANIMALS; CAPRYLATES; DIGESTIVE SYSTEM; EMULSIFYING AGENTS; ESTERS; EXCIPIENTS; FATTY ACIDS; GLYCERIDES; HUMANS; HYDROGEN-ION CONCENTRATION; LIPASE; LIPOLYSIS; PANCREATIC JUICE; POLYETHYLENE GLYCOLS; SUBSTRATE SPECIFICITY; TISSUE EXTRACTS;

CANIS FAMILIARIS; SUS;

EID: 48649092538     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbalip.2008.05.006     Document Type: Article

References (54)

1. Vonderscher J., and Meinzer A. Rationale for the development of Sandimmune Neoral. Transplant Proc. 26 (1994) 2925-2927
2. Palin K.J., Wilson C.G., Davis S.S., and Phillips A.J. The effect of oils on the lymphatic absorption of DDT. J. Pharm. Pharmacol. 34 (1982) 707-710
3. Palin K.J., and Wilson C.G. The effect of different oils on the absorption of probucol in the rat. J. Pharm. Pharmacol. 36 (1984) 641-643
4. Stella V., Haslam J., Yata N., Okada H., Lindenbaum S., and Higuchi T. Enhancement of bioavailability of a hydrophobic amine antimalarial by formulation with oleic acid in a soft gelatin capsule. J. Pharm. Sci. 67 (1978) 1375-1377
5. Nazzal S., Smalyukh, Lavrentovich O.D., and Khan M.A. Preparation and in vitro characterization of a eutectic based semisolid self-nanoemulsified drug delivery system (SNEDDS) of ubiquinone: mechanism and progress of emulsion formation. Int. J. Pharm. 235 (2002) 247-265
6. Charman W.N., Porter C.J., Mithani S., and Dressman J.B. Physiochemical and physiological mechanisms for the effects of food on drug absorption: the role of lipids and pH. J. Pharm. Sci. 86 (1997) 269-282
7. Devani M., Ashford M., and Craig D.Q. The emulsification and solubilisation properties of polyglycolysed oils in self-emulsifying formulations. J. Pharm. Pharmacol. 56 (2004) 307-316
8. Holm R., Porter C.J., Edwards G.A., Mullertz A., Kristensen H.G., and Charman W.N. Examination of oral absorption and lymphatic transport of halofantrine in a triple-cannulated canine model after administration in self-microemulsifying drug delivery systems (SMEDDS) containing structured triglycerides. Eur. J. Pharm. Sci. 20 (2003) 91-97
9. Khoo S.M., Humberstone A.J., Porter C.J.H., Edwards G.A., and Charman W.N. Formulation design and bioavailability assessment of lipidic self-emulsifying formulations of halofantrine. Int. J. Pharm. 167 (1998) 155-164
10. Porter C.J., Trevaskis N.L., and Charman W.N. Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs. Nat. Rev. Drug. Discov. 6 (2007) 231-248
11. Charman S.A., Charman W.N., Rogge M.C., Wilson T.D., Dutko F.J., and Pouton C.W. Self-emulsifying drug delivery systems: formulation and biopharmaceutic evaluation of an investigational lipophilic compound. Pharm. Res. 9 (1992) 87-93
12. Craig D.Q.M., Lievens H.S.R., Pitt K.G., and Storey D.E. An investigation into the physicochemical properties of self-emulsifying systems using low-frequency dielectric-spectroscopy, surface-tension measurements and particle size analysis. Int. J. Pharm. 96 (1993) 147-155
13. Lindstrom M., Ljusberg-Wahren H., Larsson K., and Borgstrom B. Aqueous lipid phases of relevance to intestinal fat digestion and absorption. Lipids 16 (1981) 749-754
14. Charman W.N., Rogge M.C., Boddy A.W., and Berger B.M. Effect of food and a monoglyceride emulsion formulation on danazol bioavailability. J. Clin. Pharmacol. 33 (1993) 381-386
15. Pouton C.W. Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system. Eur. J. Pharm. Sci. 29 (2006) 278-287
16. Chambin O., Jannin V., Champion D., Chevalier C., Rochat-Gonthier M.H., and Pourcelot Y. Influence of cryogenic grinding on properties of a self-emulsifying formulation. Int. J. Pharm. 278 (2004) 79-89
17. Aungst B.J., Nguyen N.H., Rogers N.J., Rowe S.M., Hussain M.A., White S.J., and Shum L. Amphiphilic vehicles improve the oral bioavailability of a poorly soluble HIV protease inhibitor at high doses. Int. J. Pharm. 156 (1997) 79-88
18. Barker S.A., Yap S.P., Yuen K.H., McCoy C.P., Murphy J.R., and Craig D.Q. An investigation into the structure and bioavailability of alpha-tocopherol dispersions in Gelucire 44/14. J. Control Release 91 (2003) 477-488
19. Pillay V., and Fassihi R. A new method for dissolution studies of lipid-filled capsules employing nifedipine as a model drug. Pharm. Res. 16 (1999) 333-337
20. Hulsmann S., Backensfeld T., Keitel S., and Bodmeier R. Melt extrusion-an alternative method for enhancing the dissolution rate of 17beta-estradiol hemihydrate. Eur. J. Pharm. Biopharm. 49 (2000) 237-242
21. Hauss D.J., Fogal S.E., Ficorilli J.V., Price C.A., Roy T., Jayaraj A.A., and Keirns J.J. Lipid-based delivery systems for improving the bioavailability and lymphatic transport of a poorly water-soluble LTB4 inhibitor. J. Pharm. Sci. 87 (1998) 164-169
22. Iwanaga K., Kushibiki T., Miyazaki M., and Kakemi M. Disposition of lipid-based formulation in the intestinal tract affects the absorption of poorly water-soluble drugs. Biol. Pharm. Bull. 29 (2006) 508-512
23. Mehuys E., Remon J.P., Korst A., Van Bortel L., Mols R., Augustijns P., Porter C., and Vervaet C. Human bioavailability of propranolol from a matrix-in-cylinder system with a HPMC-Gelucire core. J. Control Release 107 (2005) 523-536
24. Yuksel N., Karatas A., Ozkan Y., Savaser A., Ozkan S.A., and Baykara T. Enhanced bioavailability of piroxicam using Gelucire 44/14 and labrasol: in vitro and in vivo evaluation. Eur. J. Pharm. Biopharm. 56 (2003) 453-459
25. Fernandez S., Jannin V., Rodier J.D., Ritter N., Mahler B., and Carriere F. Comparative study on digestive lipase activities on the self emulsifying excipient Labrasol, medium chain glycerides and PEG esters. Biochim. Biophys. Acta 1771 (2007) 633-640
26. Sek L., Porter C.J., and Charman W.N. Characterisation and quantification of medium chain and long chain triglycerides and their in vitro digestion products, by HPTLC coupled with in situ densitometric analysis. J. Pharm. Biomed. Anal. 25 (2001) 651-661
27. Sek L., Porter C.J., Kaukonen A.M., and Charman W.N. Evaluation of the in-vitro digestion profiles of long and medium chain glycerides and the phase behaviour of their lipolytic products. J. Pharm. Pharmacol. 54 (2002) 29-41
28. Carriere F., Barrowman J.A., Verger R., and Laugier R. Secretion and contribution to lipolysis of gastric and pancreatic lipases during a test meal in humans. Gastroenterology 105 (1993) 876-888
29. Lengsfeld H., Beaumier-Gallon G., Chahinian H., De Caro A., Verger R., Laugier R., and Carrière F. Physiology of gastrointestinal lipolysis and therapeutical use of lipases and digestive lipase inhibitors. In: Petry S. (Ed). Lipases and phospholipases in drug development (2004), Wiley-VCH, Weinheim 195-229
30. Belle V., Fournel A., Woudstra M., Ranaldi S., Prieri F., Thome V., Currault J., Verger R., Guigliarelli B., and Carriere F. Probing the opening of the pancreatic lipase lid using site-directed spin labeling and EPR spectroscopy. Biochemistry 46 (2007) 2205-2214
31. Eydoux C., De Caro J., Ferrato F., Boullanger P., Lafont D., Laugier R., Carrière F., and De Caro A. Further biochemical characterization of human pancreatic lipase-related protein 2 expressed in yeast cells. J. Lipid. Res. 48 (2007) 1539-1549
32. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
33. Gargouri Y., Pieroni G., Riviere C., Lowe P.A., Sauniere J.F., Sarda L., and Verger R. Importance of human gastric lipase for intestinal lipolysis: an in vitro study. Biochim. Biophys. Acta 879 (1986) 419-423
34. Aloulou A., Rodriguez J.A., Puccinelli D., Mouz N., Leclaire J., Leblond Y., and Carriere F. Purification and biochemical characterization of the LIP2 lipase from Yarrowia lipolytica. Biochim. Biophys. Acta 1771 (2007) 228-237
35. Thirstrup K., Carriere F., Hjorth S., Rasmussen P.B., Woldike H., Nielsen P.F., and Thim L. One-step purification and characterization of human pancreatic lipase expressed in insect cells. FEBS Lett. 327 (1993) 79-84
36. Christensen J.O., Schultz K., Mollgaard B., Kristensen H.G., and Mullertz A. Solubilisation of poorly water-soluble drugs during in vitro lipolysis of medium- and long-chain triacylglycerols. Eur. J. Pharm. Sci. 23 (2004) 287-296
37. Ljusberg-Wahren H., Seier Nielsen F., Brogard M., Troedsson E., and Mullertz A. Enzymatic characterization of lipid-based drug delivery systems. Int. J. Pharm. 298 (2005) 328-332
38. Eydoux C., Aloulou A., De Caro J., Grandval P., Laugier R., Carriere F., and De Caro A. Human pancreatic lipase-related protein 2: Tissular localization along the digestive tract and quantification in pancreatic juice using a specific ELISA. Biochim. Biophys. Acta. 1760 (2006) 1497-1504
39. Giller T., Buchwald P., Blum-Kaelin D., and Hunziker W. Two novel human pancreatic lipase related proteins, hPLRP1 and hPLRP2. J. Biol. Chem. 267 (1992) 16509-16516
40. De Caro J., Sias B., Grandval P., Ferrato F., Halimi H., Carriere F., and De Caro A. Characterization of pancreatic lipase-related protein 2 isolated from human pancreatic juice. Biochim. Biophys. Acta 1701 (2004) 89-99
41. Reboul E., Berton A., Moussa M., Kreuzer C., Crenon I., and Borel P. Pancreatic lipase and pancreatic lipase-related protein 2, but not pancreatic lipase-related protein 1, hydrolyze retinyl palmitate in physiological conditions. Biochim. Biophys. Acta 1761 (2006) 4-10
42. Rudd E.A., and Brockman H.L. Pancreatic carboxyl ester lipase (cholesterol esterase). In: Brockman H.L. (Ed). Lipases (1984), Elsevier Science Publishers, Amsterdam 185-204
43. Figarella C. Composition et stabilité de l'équipement enzymatique du pancréas de l'holle et de divers animaux. Bulletin Société de Chimie Biologique 48 (1966) 97-115
44. Guy O., and Figarella C. The proteins of human pancreatic external secretion. Scand. J. Gastroenterol. Suppl. 67 (1981) 59-61
45. Kyger E.M., Wiegand R.C., and Lange L.G. Cloning of the bovine pancreatic cholesterol esterase/lysophospholipase. Biochem. Biophys. Res. Commun. 164 (1989) 1302-1309
46. Nilsson J., Blaeckberg L., Carlsson P., Enerbaeck S., Hernell O., and Bjursell G. cDNA cloning of human-milk bile-salt-stimulated lipase and evidence for its identity to pancreatic carboxylic ester hydrolase. Eur. J. Biochem. 192 (1990) 543-550
47. Chen J.C., Miercke L.J., Krucinski J., Starr J.R., Saenz G., Wang X., Spilburg C.A., Lange L.G., Ellsworth J.L., and Stroud R.M. Structure of bovine pancreatic cholesterol esterase at 1.6 A: novel structural features involved in lipase activation. Biochemistry 37 (1998) 5107-5117
48. Moore S.A., Kingston R.L., Loomes K.M., Hernell O., Blackberg L., Baker H.M., and Baker E.N. The structure of truncated recombinant human bile salt-stimulated lipase reveals bile salt-independent conformational flexibility at the active-site loop and provides insights into heparin binding. J. Mol. Biol. 312 (2001) 511-523
49. Carrière F., Moreau H., Gargouri Y., Cudrey C., Ferrato F., Bernadac A., Bénicourt C., Junien J.-L., and Verger R. Human gastric lipase. GBF Monogr. 16 (1991) 129-133
50. Carrière F., Bezzine S., and a.V. R., Molecular evolution of the Pancreatic lipase and two related enzymes towards different substrate selectivities. Journal of Molecular Catalysis B: Enzymatic 3 (1997) 55-64
51. Vaganay S., Joliff G., Bertaux O., Toselli E., Devignes M.D., and Benicourt C. The complete cDNA sequence encoding dog gastric lipase. DNA Seq. 8 (1998) 257-262
52. Bodmer M.W., Angal S., Yarranton G.T., Harris T.J., Lyons A., King D.J., Pieroni G., Riviere C., Verger R., and Lowe P.A. Molecular cloning of a human gastric lipase and expression of the enzyme in yeast. Biochim. Biophys. Acta 909 (1987) 237-244
53. Roussel A., Canaan S., Egloff M.P., Riviere M., Dupuis L., Verger R., and Cambillau C. Crystal structure of human gastric lipase and model of lysosomal acid lipase, two lipolytic enzymes of medical interest. J. Biol. Chem. 274 (1999) 16995-17002
54. Roussel A., Miled N., Berti-Dupuis L., Riviere M., Spinelli S., Berna P., Gruber V., Verger R., and Cambillau C. Crystal structure of the open form of dog gastric lipase in complex with a phosphonate inhibitor. J. Biol. Chem. 277 (2002) 2266-2274